|
US7820422B2
(en)
|
2005-06-16 |
2010-10-26 |
Centre National De La Recherche Scientifique (Cnrs) |
Efficient production of oligosaccharides using metabolically engineered microorganisms
|
|
US20070202578A1
(en)
*
|
2005-08-26 |
2007-08-30 |
Centre National De La Recherche Scientifique (Cnrs) |
Production of globosides oligosaccharides using metabolically engineered microorganisms
|
|
WO2010070104A1
(en)
*
|
2008-12-19 |
2010-06-24 |
Jennewein Biotechnologie Gmbh |
Synthesis of fucosylated compounds
|
|
EP2593549A2
(en)
*
|
2010-07-12 |
2013-05-22 |
Universiteit Gent |
Metabolically engineered organisms for the production of added value bio-products
|
|
CA3024641A1
(en)
*
|
2010-11-03 |
2012-05-10 |
Corbion Biotech, Inc. |
Microbial oils with lowered pour points, dielectric fluids produced therefrom, and related methods
|
|
US9816107B2
(en)
|
2011-07-29 |
2017-11-14 |
The University Of Wyoming |
Transgenic insect cells comprising a bacterial GlcNAc-6-P 2′-epimerase
|
|
WO2013019625A2
(en)
|
2011-07-29 |
2013-02-07 |
The University Of Wyoming |
Methods of using a bacterial glcnac-6-p 2'-epimerase to promote sialylation of glycoconjugates
|
|
EP2900829B1
(en)
*
|
2012-09-25 |
2019-06-26 |
Glycom A/S |
Glycoconjugate synthesis
|
|
WO2014135167A1
(en)
*
|
2013-03-08 |
2014-09-12 |
Glycom A/S |
Purification of oligosaccaharides by reversible derivatization
|
|
WO2014153253A1
(en)
*
|
2013-03-14 |
2014-09-25 |
Glycosyn LLC |
Microorganisms and methods for producing sialylated and n-acetylglucosamine-containing oligosaccharides
|
|
EP2999358B1
(en)
|
2013-05-22 |
2021-07-07 |
Glycom A/S |
Synthetic mixture of oligosaccharides for the treating a microbiota of a mammal
|
|
CN104342469B
(zh)
*
|
2013-08-01 |
2017-06-30 |
东北师范大学 |
一种生物转化制备单唾液酸四己糖神经节苷脂的方法
|
|
WO2015032413A1
(en)
*
|
2013-09-06 |
2015-03-12 |
Glycom A/S |
Fermentative production of oligosaccharides
|
|
CN103602627B
(zh)
*
|
2013-11-25 |
2015-03-18 |
武汉中科光谷绿色生物技术有限公司 |
一种产n-乙酰神经氨酸大肠杆菌工程菌及其构建方法和应用
|
|
US10731193B2
(en)
|
2014-06-27 |
2020-08-04 |
Glycom A/S |
Oligosaccharide production
|
|
US11926858B2
(en)
|
2014-06-27 |
2024-03-12 |
Glycom A/S |
Oligosaccharide production
|
|
US9616114B1
(en)
|
2014-09-18 |
2017-04-11 |
David Gordon Bermudes |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
|
|
ES2824679T5
(es)
|
2014-10-24 |
2023-12-11 |
Glycom As |
Mezclas de oligosacáridos de la leche humana
|
|
EP3212198B1
(en)
|
2014-10-29 |
2020-12-23 |
Glycom A/S |
Synthetic composition and method for promoting mucosal healing
|
|
US11040049B2
(en)
|
2014-10-29 |
2021-06-22 |
Glycom A/S |
Composition comprising HMSs/HMOs and use thereof
|
|
WO2016066175A1
(en)
|
2014-10-29 |
2016-05-06 |
Glycom A/S |
Synthetic composition and method for treating irritable bowel syndrome
|
|
US11040050B2
(en)
|
2014-10-29 |
2021-06-22 |
Glycom A/S |
Composition comprising HMSs/HMOs and use thereof
|
|
KR102579346B1
(ko)
*
|
2014-11-14 |
2023-09-15 |
인바이오스 엔.브이. |
락토스 사멸에 내성인 돌연변이 미생물
|
|
US10835544B2
(en)
|
2014-12-08 |
2020-11-17 |
Glycom A/S |
Synthetic composition for regulating satiety
|
|
US10881674B2
(en)
|
2014-12-08 |
2021-01-05 |
Glycom A/S |
Synthetic composition for treating metabolic disorders
|
|
WO2016091265A1
(en)
|
2014-12-08 |
2016-06-16 |
Glycom A/S |
Synthetic composition for treating metabolic disorders
|
|
US10987368B2
(en)
|
2014-12-08 |
2021-04-27 |
Glycom A/S |
Synthetic composition for preventing or treating CVD
|
|
ES2971093T3
(es)
|
2015-03-31 |
2024-06-03 |
Glycom As |
Mezclas de oligosacáridos de la leche humana que comprenden 3'-O-sialilactosa
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
WO2016199071A1
(en)
|
2015-06-09 |
2016-12-15 |
Glycom A/S |
TERNARY MIXTURES OF 6'-SL, LNnT and LST c
|
|
EP3141610A1
(en)
*
|
2015-09-12 |
2017-03-15 |
Jennewein Biotechnologie GmbH |
Production of human milk oligosaccharides in microbial hosts with engineered import / export
|
|
ES2886951T3
(es)
|
2015-09-14 |
2021-12-21 |
Glycom As |
Composición para su uso en la modulación de la microbiota
|
|
DK3368046T3
(da)
|
2015-10-28 |
2022-10-31 |
Glycom As |
Synthetic composition and method for modulating brain function and behaviour
|
|
EP3368047B1
(en)
|
2015-10-28 |
2023-04-26 |
Glycom A/S |
Synthetic composition and method for modulating emotion and mood disorders
|
|
US10864224B2
(en)
|
2015-11-17 |
2020-12-15 |
Glycom A/S |
Synthetic composition for treating antibiotic associated complications
|
|
CA3006400A1
(en)
*
|
2015-11-30 |
2017-06-08 |
Limmatech Biologics Ag |
Methods of producing glycosylated proteins
|
|
BR112018010505B1
(pt)
|
2015-12-15 |
2021-11-16 |
Société des Produits Nestlé S.A. |
Composições para bebês e crianças pequenas, e uso de uma mistura sintética de hmos
|
|
WO2017101958A1
(en)
|
2015-12-18 |
2017-06-22 |
Glycom A/S |
Fermentative production of oligosaccharides
|
|
WO2017144062A1
(en)
|
2016-02-24 |
2017-08-31 |
Glycom A/S |
Synthetic composition for microbiota modulation
|
|
EP3426670B1
(en)
|
2016-03-07 |
2024-08-07 |
Glycom A/S |
Separation of oligosaccharides from fermentation broth
|
|
EP3452050B1
(en)
|
2016-05-05 |
2022-11-23 |
Glycom A/S |
Composition comprising hmos for the treatment of non-infectious diarrhoea
|
|
DK3452051T3
(en)
|
2016-05-05 |
2022-09-05 |
Glycom As |
COMPOSITION COMPRISING HMOs FOR USE IN THE TREATMENT OF MAST CELL MEDIATED VISCERAL HYPERSENSITIVITY AND/OR PAIN
|
|
WO2017198276A1
(en)
|
2016-05-19 |
2017-11-23 |
Glycom A/S |
Synthetic composition
|
|
CN119523994A
(zh)
|
2016-06-24 |
2025-02-28 |
格礼卡姆股份公司 |
包括hmo的组合物、其制备和用于预防和/或治疗病毒和/或细菌感染的用途
|
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
BR112019013211A2
(pt)
|
2016-12-27 |
2019-12-10 |
Inbiose N.V. |
síntese in vivo de compostos sialilados
|
|
EP3589139A4
(en)
|
2017-03-01 |
2020-12-23 |
Glycom A/S |
SYNTHETIC COMPOSITION FOR MICROBIOTE MODULATION
|
|
EP3634429A4
(en)
|
2017-05-09 |
2020-11-04 |
Glycom A/S |
SYNTHETIC COMPOSITION FOR MICROBIOTE MODULATION
|
|
US11541068B2
(en)
|
2017-05-24 |
2023-01-03 |
Glycom A/S |
HMO compositions and methods for reducing autism spectrum disorder symptoms
|
|
EP3630123A4
(en)
|
2017-05-24 |
2020-10-28 |
Glycom A/S |
SYNTHETIC COMPOSITION CONSISTING OF ONE OR MORE HUMAN MILK OLIGOSACCHARIDES (HMOS)
|
|
EP3645545A4
(en)
|
2017-06-30 |
2021-05-05 |
Glycom A/S |
PURIFICATION OF OLIGOSACCHARIDES
|
|
EP3652189A4
(en)
|
2017-07-12 |
2021-04-21 |
Glycom A/S |
AMORPHIC MIXTURE CONSISTING OF A NEUTRAL MONO- OR OLIGOSACCHARIDE AND A NON-GLUCIDIC ACID COMPONENT
|
|
AU2018305183A1
(en)
|
2017-07-26 |
2020-02-13 |
Chr. Hansen HMO GmbH |
Sialyltransferases and their use in producing sialylated oligosaccharides
|
|
WO2019038668A1
(en)
|
2017-08-21 |
2019-02-28 |
Glycom A/S |
SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
|
|
EP3456836A1
(en)
|
2017-09-13 |
2019-03-20 |
Glycom A/S |
Separation of sialylated oligosaccharides from fermentation broth
|
|
EP3691658A4
(en)
|
2017-10-04 |
2021-06-23 |
The Regents of The University of California |
IMMUNOMODULATOR OLIGOSACCHARIDES
|
|
US11541069B2
(en)
|
2017-11-02 |
2023-01-03 |
Glycom A/S |
One or more HMOs for reducing or preventing fatigue and/or improving focus or concentration
|
|
ES2987964T3
(es)
|
2017-11-30 |
2024-11-18 |
Glycom As |
Mezcla de HMO para tratar la sensibilidad al trigo
|
|
CN111556755A
(zh)
|
2017-12-05 |
2020-08-18 |
格礼卡姆股份公司 |
用于治疗偏头痛的人乳寡糖
|
|
WO2019118829A2
(en)
*
|
2017-12-15 |
2019-06-20 |
Glycosyn LLC |
Sialyltransferases and uses thereof
|
|
CN111683666A
(zh)
|
2017-12-22 |
2020-09-18 |
格礼卡姆股份公司 |
预防或减少伤害感受的包含hmo的组合物
|
|
GB2573539A
(en)
|
2018-05-09 |
2019-11-13 |
Mjn Us Holdings Llc |
Wellbeing supplement for postpartum maternal nutrition
|
|
EP3575404B1
(en)
|
2018-05-28 |
2022-10-19 |
Chr. Hansen HMO GmbH |
Fermentative production of sialylated saccharides
|
|
CN112165947A
(zh)
|
2018-05-31 |
2021-01-01 |
格礼卡姆股份公司 |
用于治疗自身免疫性疾病的hmo混合物
|
|
ES2933959T3
(es)
*
|
2018-06-01 |
2023-02-15 |
Chr Hansen Hmo Gmbh |
Un método simple para la purificación de una sialil-lactosa
|
|
EP3891291A4
(en)
*
|
2018-12-04 |
2022-10-26 |
Glycom A/S |
Synthesis of the fucosylated oligosaccharide lnfp-v
|
|
JP2022513524A
(ja)
|
2018-12-19 |
2022-02-08 |
グリコム・アクティーゼルスカブ |
低ｆｏｄｍａｐ食を使用してヒトを治療するための組成物および方法
|
|
CN109852651B
(zh)
|
2018-12-27 |
2022-03-15 |
大连大学 |
一种重组大肠杆菌质周腔内生产唾液酸修饰n-糖基化重组蛋白方法
|
|
CN110195043A
(zh)
*
|
2019-05-15 |
2019-09-03 |
武汉格莱利生物科技有限公司 |
一种高水溶性的cgta酶及其制备方法和应用
|
|
EP3789495A1
(en)
*
|
2019-09-03 |
2021-03-10 |
Jennewein Biotechnologie GmbH |
Production of sialylated oligosaccharides in bacillus cells
|
|
WO2021081670A1
(en)
*
|
2019-11-01 |
2021-05-06 |
The University Of British Columbia |
Compositions and methods for sialylated mucin-type o-glycosylation of therapeutic proteins
|
|
WO2021094133A2
(en)
|
2019-11-13 |
2021-05-20 |
Basf Se |
Enzymatic hydrolysis of 2',3-difucosyllactose
|
|
CN114901825A
(zh)
|
2019-12-18 |
2022-08-12 |
因比奥斯公司 |
在宿主细胞中产生唾液酸化寡糖
|
|
JP2023507247A
(ja)
*
|
2019-12-19 |
2023-02-22 |
グリコム・アクティーゼルスカブ |
発酵ブロスからのシアリル化オリゴ糖の分離
|
|
EP3848471A1
(en)
*
|
2020-01-10 |
2021-07-14 |
Chr. Hansen HMO GmbH |
Sequential fermentative production of oligosaccharides
|
|
WO2021170620A1
(en)
|
2020-02-24 |
2021-09-02 |
Carbocode S.A. |
Synthesis of glycosyl fluorides
|
|
EP4110934A1
(en)
|
2020-02-24 |
2023-01-04 |
Carbocode S.A. |
Synthesis of c-glycosides of interest
|
|
CN115151651A
(zh)
|
2020-02-24 |
2022-10-04 |
碳码股份公司 |
目的糖基化鞘氨醇碱或其类似物的合成
|
|
CN111500660A
(zh)
*
|
2020-04-23 |
2020-08-07 |
武汉糖智药业有限公司 |
一种单唾液酸四己糖神经节苷脂的合成方法
|
|
EP3954778B1
(en)
|
2020-08-10 |
2023-10-04 |
Inbiose N.V. |
Production of a mixture of neutral non-fucosylated oligosaccharides by a cell
|
|
EP3954769A1
(en)
*
|
2020-08-10 |
2022-02-16 |
Inbiose N.V. |
Production of oligosaccharide mixtures by a cell
|
|
FR3110176B1
(fr)
|
2020-05-12 |
2022-05-13 |
Institut Nat Des Sciences Appliquees De Toulouse |
Souche et procédé de production d’oligosaccharides
|
|
WO2022034068A1
(en)
*
|
2020-08-10 |
2022-02-17 |
Inbiose N.V. |
Production of a mixture of mammalian milk oligosaccharides by a cell
|
|
WO2022130322A1
(en)
*
|
2020-12-18 |
2022-06-23 |
Glycom A/S |
Separation of charged oligosaccharides
|
|
US20240102063A1
(en)
|
2021-01-22 |
2024-03-28 |
Glycom A/S |
New major facilitator superfamily (mfs) protein (fred) in production of sialylated hmos
|
|
PT4284843T
(pt)
|
2021-01-29 |
2025-10-16 |
Univ Claude Bernard Lyon |
Sialósidos inovadores e sua utilização em terapia
|
|
DK181061B1
(en)
|
2021-03-12 |
2022-10-31 |
Glycom As |
Purification of sialooligosaccharides
|
|
US20240200021A1
(en)
*
|
2021-04-16 |
2024-06-20 |
Inbiose N.V. |
Cellular production of sialylated di- and/or oligosaccharides
|
|
US20240191270A1
(en)
|
2021-04-16 |
2024-06-13 |
Inbiose N.V. |
Fermentative production
|
|
WO2022223430A1
(en)
|
2021-04-19 |
2022-10-27 |
Dsm Ip Assets B.V. |
A composition of enzymes and human milk oligosaccharides
|
|
AU2021446678A1
(en)
|
2021-05-20 |
2023-12-07 |
Chr. Hansen A/S |
Sequential fermentative production of oligosaccharides
|
|
WO2022263425A1
(en)
|
2021-06-15 |
2022-12-22 |
Dsm Ip Assets B.V. |
Separation of human milk oligosaccharides from a fermentation broth
|
|
BE1029434B1
(nl)
|
2021-06-15 |
2023-07-31 |
Dsm Ip Assets Bv |
Scheiding van moedermelkoligosachariden uit een fermentatiebouillon
|
|
US20240286081A1
(en)
|
2021-06-15 |
2024-08-29 |
Dsm Ip Assets B.V. |
Separation of human milk oligosaccharides from a fermentation broth
|
|
WO2022263426A1
(en)
|
2021-06-15 |
2022-12-22 |
Dsm Ip Assets B.V. |
Separation of human milk oligosaccharides from a fermentation broth
|
|
US20240335558A1
(en)
*
|
2021-12-02 |
2024-10-10 |
Glyco-Therapy Biotechnology Co., Ltd. |
Isolated polypeptide and use thereof
|
|
DK181683B1
(en)
|
2022-03-02 |
2024-09-20 |
Dsm Ip Assets Bv |
Cells exprssing new sialyltransferases for in vivo synthesis of lst-a, methods using same and constructs encoding said sialyltransferases
|
|
DK181319B1
(en)
|
2022-03-02 |
2023-08-10 |
Dsm Ip Assets Bv |
Genetically engineered cells and methods comprising use of a sialyltransferase for in vivo synthesis of 3’sl
|
|
EP4486897A2
(en)
|
2022-03-02 |
2025-01-08 |
DSM IP Assets B.V. |
New sialyltransferases for in vivo synthesis of 3'sl and 6'sl
|
|
CN114965543B
(zh)
*
|
2022-06-13 |
2023-10-20 |
青岛科技大学 |
壳寡糖nmr波谱的归属及脱乙酰度相关指标的测定方法
|
|
DK202200588A1
(en)
|
2022-06-20 |
2024-02-23 |
Dsm Ip Assets Bv |
Mixture of fucosylated HMOs
|
|
DK202200591A1
(en)
|
2022-06-20 |
2024-02-15 |
Dsm Ip Assets Bv |
New sialyltransferases for in vivo synthesis of lst-c
|
|
CN115094103A
(zh)
*
|
2022-07-22 |
2022-09-23 |
南宁东恒华道生物科技有限责任公司 |
以蔗糖、淀粉或糖原为原料组合酶法生产半乳糖的新工艺
|
|
CN117778345A
(zh)
*
|
2024-01-14 |
2024-03-29 |
北京睿脉医药科技有限公司 |
可固化和重复利用的幽门螺杆菌岩藻糖基转移酶突变体
|
|
CN119876092B
(zh)
*
|
2024-12-30 |
2025-10-31 |
嘉必优生物技术（武汉）股份有限公司 |
一种尿苷5′-二磷酸-n-乙酰氨基葡萄糖2差向异构酶的突变体及其应用
|